Načítá se...
Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001
Polycythemia vera (PV) is a chronic myeloproliferative neoplasm (MPN) characterized by excessive production of red blood cells. Patients with PV are at a risk of thrombosis, bleeding, and transformation to myelofibrosis or acute myeloid leukemia. Therapy for PV is based on the use of phlebotomy, asp...
Uloženo v:
| Vydáno v: | Int J Hematol |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2009
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4378576/ https://ncbi.nlm.nih.gov/pubmed/19484334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12185-009-0345-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|